Akers biosciences, inc. (AKER)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Product Revenue

1,577

1,665

3,354

-

-

-

-

Product Revenue

-

-

-

2,956

1,757

2,453

1,325

Product Revenue - Related party

-

-

-

0

36

1,630

1,719

License & Service Revenue

-

-

-

3

15

10

200

License Revenue - Related party

-

-

-

-

305

333

333

Total Revenues

-

-

-

2,960

2,115

4,427

3,577

Product Cost of Sales

1,098

1,538

2,406

-

-

-

-

Product Cost of Sales

-

-

-

1,083

950

1,175

1,913

Gross Income

478

127

948

1,877

1,164

3,251

1,664

Sales and Marketing Expenses - Related Party

-

-

-

153

0

-

-

Sales and Marketing Expenses - Related party

-

-

-

-

-

195

428

Research and Development Expenses

276

1,063

1,260

1,188

1,406

916

1,006

Administrative Expenses

3,728

5,666

4,082

3,008

4,029

3,784

1,095

Sales and Marketing Expenses

238

1,782

2,048

1,983

2,543

1,302

684

Research and Development Expenses - Related Party

-

-

-

0

-

-

-

Litigation Settlement Expenses

141

1,505

-

-

-

-

-

Reversal of Allowance Related parties

-

-

-

-1,299

-

-

-

(Reversal of Allowance for) Bad Debt Expenses- Related parties

-

-

-

-

2,163

-

-

Impairment of Non-Current Assets

-

-

-

-

466

0

-

Amortization of Non-Current Assets

40

171

171

171

236

258

258

Loss from Operations

-3,946

-10,060

-6,613

-3,328

-9,682

-3,204

-1,810

Other (Income) Expenses
Impairment of Intangible Assets

32

716

-

-

-

-

-

Impairment of Non-Current Assets

-

64

-

-

-

-

-

Loss on Disposal of Property and Equipment

9

156

-

-

-

-

-

Gain on sale of equity investment - Related party

-

-

-

-

-

-

99

Foreign Currency Transaction Loss

5

6

-1

3

7

-2

-0

Other Income

-

-

-

-

-6

-

-

Other Income

-

4

-

-

-

-

91

Loss on Investments

-3

15

-

-

-

-

-

Warrant Modification Expense

-

-

764

0

-

-

-

Gain from demutualization of insurance carrier

-

-

-

-

-

-4

91

Interest and Dividend Income

101

165

10

21

-102

-69

1

Total Other Income

-57

788

752

25

-100

-76

283

Loss Before Income Taxes

-3,888

-10,849

-7,366

-3,303

-9,581

-3,127

-1,526

Income Tax Benefit

-

-

-

0

-269

0

0

Preferred Stock Dividend

-

-

-

-

-

-15

0

Net Loss

-3,888

-10,849

-7,366

-3,303

-9,311

-3,142

-

Other Comprehensive Income (Loss)
Net Loss Attributable to Common Stockholders

-

-

-

-

-

-

-1,526

Net Unrealized Gain (Loss) on Marketable Securities

43

-25

-

6

13

-20

0

Total Other Comprehensive Income (Loss)

43

-25

-

-

-

-

-

Comprehensive Loss

-3,844

-10,874

-

-

-

-

-

Total Other Comprehensive Loss

-

-

-

6

13

-20

0

Comprehensive Loss

-

-

-7,366

-3,297

-9,298

-3,163

-1,526

Basic and Diluted loss per common share

-6.35

-22.28

-6.29

-0.61

-1.81

-0.66

-0.96

Weighted average basic and diluted common shares outstanding

612

486

1,171

5,430

5,140

4,745

1,596

Product Revenue [Member]
Total Revenues

-

-

3,304

-

-

-

-

License Fees [Member]
Total Revenues

-

-

50

-

-

-

-